| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |